Bed Capacity Data Analysis for Ronald Reagan Medical Center from Q1 2022 to Q3 2024 License Agreement
Copyright (c) 2024 Christopher Fu, Biodesign Program at UCLA Health

This license governs the use of the software, models, and datasets (collectively referred to as "the Assets") associated with Bed Capacity Data Analysis for Ronald Reagan Medical Center from Q1 2022 to Q3 2024 (the "Project"). By accessing or using the Assets, you agree to the terms outlined below.

1. **Authorized Use**:
   - The Assets may only be used by UCLA Health for internal purposes related to approved medical or research activities.
   - Redistribution, sublicensing, or sharing of the Assets is strictly prohibited without prior written consent.

2. **Data Restrictions**:
   - The datasets provided as part of the Project may contain sensitive medical information and are protected under applicable laws (e.g., HIPAA, GDPR).
   - Users are prohibited from accessing, processing, or sharing patient data for unauthorized purposes.

3. **Model and Software Restrictions**:
   - Trained models and software provided are proprietary and may only be used for approved medical or research purposes.
   - Retraining, reverse engineering, or integrating the models into other systems is prohibited unless explicitly authorized.

4. **Ethical Use**:
   - Users must ensure that the Assets are used in a manner consistent with medical ethics and professional standards.
   - Any use of the Assets that could harm patients or compromise medical integrity is strictly prohibited.

5. **Confidentiality**:
   - All aspects of the Project, including datasets, models, and insights, are confidential and proprietary.
   - Users must not disclose any information related to the Assets to unauthorized third parties.

6. **Liability and Warranty**:
   - The Assets are provided "as is," without warranty of any kind, express or implied, including but not limited to fitness for medical purposes or accuracy of results.
   - The copyright holder shall not be held liable for any direct, indirect, or consequential damages resulting from the use or inability to use the Assets.

7. **Regulatory Compliance**:
   - Users are responsible for ensuring compliance with all applicable healthcare laws and regulations when using the Assets

8. **Termination**:
   - This license agreement may be terminated by the copyright holder at any time with or without cause.
   - Upon termination, users must destroy all copies of the Assets in their possession.

Christopher Fu, Biodesign Program at UCLA Health 
email: christopherfuwas@gmail.com
